Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Collegium Pharmaceutical (COLL)
NASDAQ:COLL
RESEARCH TOOLSreports
Collegium Pharmaceutical (COLL) Ownership Overview
4.44% Insiders
37.98% Mutual Funds
0.90% Other Institutional Investors
32.65% ETFs
24.03% Public Companies and Individual Investors
The ownership structure of Collegium Pharmaceutical (COLL) stock is a mix of institutional, retail, and individual investors. Approximately 71.53% of the company’s stock is owned by Institutional Investors, 4.44% is owned by Insiders, and 24.03% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 17, 2024 | Thomas B Smith Evp And Chief Medical Officer | xxxxxxxxxxxxx | $351296 |
| Sep 06, 2024 | Shirley R. Kuhlmann Evp & Gc | xxxxxxxxxxxxx | $773781 |
| May 28, 2024 | Scott Dreyer Evp & Cco | xxxxxxxxxxxxx | $3662190 |
| May 16, 2024 | Garen Bohlin Director | xxxxxxxxxxxxx | $936216 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $417459 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $804320 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $902475 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $5827438 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,849,795 | Institution | 11.94% | 114,184,920 | |
| 2,629,593 | Institution | 8.15% | 77,993,728 | |
| 1,956,865 | Institution | 6.07% | 58,040,616 | |
| 1,911,348 | Institution | 5.93% | 56,690,582 | |
| 1,466,915 | Institution | 4.55% | 43,508,699 | |
| 1,305,864 | Institution | 4.05% | 38,731,926 | |
| 830,051 | Institution | 2.57% | 24,619,313 | |
| 724,750 | Institution | 2.25% | 21,496,085 | |
| 649,476 | Institution | 2.01% | 19,263,458 | |
| 616,951 | Institution | 1.91% | 18,298,767 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,629,593 | Institution | 8.15% | 77,993,728 | |
| 1,466,915 | Institution | 4.55% | 43,508,699 | |
| 1,305,864 | Institution | 4.05% | 38,731,926 | |
| 830,051 | Institution | 2.57% | 24,619,313 | |
| 616,951 | Institution | 1.91% | 18,298,767 | |
| 396,000 | Institution | 1.23% | 11,745,360 | |
| 355,088 | Institution | 1.10% | 10,531,910 | |
| 341,127 | Institution | 1.06% | 10,117,827 | |
| 324,060 | Institution | 1.00% | 9,611,620 | |
| 316,301 | Institution | 0.98% | 9,381,488 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,061,254 | Institution | 6.39% | 63,857,649 | |
| 1,954,484 | Institution | 6.06% | 60,549,914 | |
| 979,172 | Institution | 3.04% | 28,053,278 | |
| 850,536 | Institution | 2.64% | 25,226,898 | |
| 484,767 | Institution | 1.50% | 13,888,575 | |
| 298,769 | Institution | 0.93% | 8,861,489 | |
| 294,882 | Institution | 0.91% | 9,135,444 | |
| 282,793 | Institution | 0.88% | 8,387,640 | |
| 234,126 | Institution | 0.73% | 6,944,177 | |
| 225,642 | Institution | 0.70% | 6,692,542 |
FAQ
Who Owns Collegium Pharmaceutical (COLL)?
According to the latest TipRanks data, approximately 0.90% of the company's stock is held by institutional investors, 4.44% is held by insiders, and 24.03% is held by retail investors.
What percentage of Collegium Pharmaceutical (COLL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.90% of Collegium Pharmaceutical (COLL) stock is held by institutional investors.
What percentage of Collegium Pharmaceutical (COLL) stock is held by retail investors?
According to the latest TipRanks data, approximately 24.03% of Collegium Pharmaceutical (COLL) stock is held by retail investors.
Who owns the most shares of Collegium Pharmaceutical (COLL)?
iShares owns the most shares of Collegium Pharmaceutical (COLL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.